0001209191-22-057401.txt : 20221116
0001209191-22-057401.hdr.sgml : 20221116
20221116192532
ACCESSION NUMBER: 0001209191-22-057401
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221114
FILED AS OF DATE: 20221116
DATE AS OF CHANGE: 20221116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOMSICEK MICHAEL JOHN
CENTRAL INDEX KEY: 0001570392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41551
FILM NUMBER: 221396538
MAIL ADDRESS:
STREET 1: 28 OVERLOOK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781174
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825125532
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-207-8979
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-14
0
0001781174
Acrivon Therapeutics, Inc.
ACRV
0001570392
TOMSICEK MICHAEL JOHN
C/O ACRIVON THERAPEUTICS, INC.
480 ARSENAL WAY, SUITE 100
WATERTOWN
MA
02472
1
0
0
0
Stock Option (Right to Buy)
12.50
2022-11-14
4
A
0
35235
0.00
A
2032-11-13
Common Stock
35235
35235
D
The shares subject to the option shall vest in 36 equal monthly installments beginning on October 12, 2022 ("Vesting Commencement Date"), such that all shares are fully vested on the third anniversary of the Vesting Commencement Date, in each case subject to the Reporting Person's continuous service through each such vesting date.
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
2022-11-16